胎儿基因调控基因缺失与精神分裂症及社区样本认知不良相关
该研究纳入617例精神分裂症谱系障碍(SSD)患者,分析已知风险拷贝数变异(CNV)和基因组范围缺失负荷与儿童期起病精神病及边缘智力功能的关系,并在233名亲属、581名对照和9930名ABCD青少年中验证边缘智力关联;发现已知SSD风险CNV和神经发育障碍风险CNV与边缘智力相关,胎儿脑发育基因调控基因缺失与边缘智力及脑结构改变相关。
要点
- 已知SSD风险CNV和NDD风险CNV与SSD患者边缘智力相关。
- 胎儿脑发育基因调控基因缺失与边缘智力相关,并在ABCD队列中可重复。
- 胎儿基因调控基因缺失与灰质体积和皮层厚度改变相关。
核心结论
- 已知风险CNV贡献于SSD严重表型,胎儿脑发育 disrupted 与认知不良相关,神经发育框架有助于识别严重SSD相关表型的机制。
研究设计与样本
- 研究纳入617例SSD患者,评估已知风险CNV、基因组范围缺失负荷评分及18个神经发育基因集缺失负荷评分与儿童期起病精神病和边缘智力功能的关联。
- 边缘智力关联在233名SSD患者亲属、581名对照和9930名ABCD研究青少年中评估可重复性。
主要发现
- 已知SSD风险CNV与SSD患者边缘智力相关(OR=7.07,95% CI=1.60, 31.32)。
- NDD风险CNV与SSD患者边缘智力相关(OR=4.56,95% CI=1.48, 14.10)。
- 胎儿脑发育基因表达调控基因缺失与SSD病例和非病例边缘智力相关(OR=2.57,95% CI=1.44, 4.60),在ABCD队列中也相关(OR=1.33,95% CI=1.00, 1.76)。
- 探索性结构MRI分析显示胎儿基因调控基因缺失与灰质体积改变(b=0.09,95% CI=0.004, 0.17)和皮层厚度改变(b=0.14,95% CI=0.05, 0.24)相关。
关键数值与推荐
- 已知SSD风险CNV与边缘智力关联的OR=7.07(95% CI=1.60, 31.32)。
- NDD风险CNV与边缘智力关联的OR=4.56(95% CI=1.48, 14.10)。
- 胎儿基因调控基因缺失与边缘智力关联的OR=2.57(95% CI=1.44, 4.60),ABCD队列中OR=1.33(95% CI=1.00, 1.76)。
临床怎么用
- 对SSD患者评估已知风险CNV有助于识别边缘智力等严重表型风险。
- 胎儿基因调控基因缺失评分可能辅助认知不良的风险分层。
局限性
- 结构MRI分析为探索性,样本量有限,需进一步验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Schizophrenia is a neurodevelopmental disorder involving clinical and genetic heterogeneity. Multiple recurrent copy number variants (CNVs) increase risk for schizophrenia spectrum disorders (SSDs). However, it is unclear how known risk CNVs and broader genome-wide CNVs influence clinical variability. Furthermore, whether biological annotation of CNV scores can improve power for patient stratification is unknown. This study therefore investigated the relationships between severe SSD-related phenotypes and varied CNV metrics, including CNV burden affecting genes involved in different aspects of neurodevelopment. METHODS: This study of 617 individuals with SSDs examined associations of two severe phenotypes-childhood-onset psychosis and borderline intellectual functioning (IQ)-with 1) known risk CNVs, 2) genome-wide deletion burden scores, and 3) novel scores capturing deletion burden in 18 previously validated and mutually exclusive gene sets, representing distinct aspects of neurodevelopment. Associations with borderline IQ were assessed for replicability in 233 relatives of SSD patients, 581 control subjects, and 9,930 youths from the Adolescent Brain Cognitive Development (ABCD) Study. RESULTS: Known SSD-risk CNVs (odds ratio=7.07, 95% CI=1.60, 31.32) and neurodevelopmental disorder (NDD)-risk CNVs (odds ratio=4.56, 95% CI=1.48, 14.10) were associated with borderline IQ in SSDs. Furthermore, beyond effects of known NDD-risk CNVs, deletion of genes involved in regulating gene expression during fetal brain development was associated with borderline IQ across SSD cases and noncases (odds ratio=2.57, 95% CI=1.44, 4.60) and in the ABCD cohort (odds ratio=1.33, 95% CI=1.00, 1.76). Exploratory structural MRI-based analyses showed associations between fetal gene regulatory gene deletions and altered gray matter volume (b=0.09, 95% CI=0.004, 0.17) and cortical thickness (b=0.14, 95% CI=0.05, 0.24) across SSD cases and noncases. CONCLUSIONS: The study results confirm contributions of known risk CNVs to severe phenotypes in SSDs, implicate disrupted fetal brain development in poor cognition, and demonstrate the utility of a neurodevelopmental framework for identifying mechanisms underlying severe SSD-relevant phenotypes.
引用
- Forsyth JK, Zhu J, Chavannes AS, et al. Association of Fetal Gene Regulatory Gene Deletions With Poor Cognition in Schizophrenia and Community-Based Samples. Am J Psychiatry. 2026. PMID: 42337417. doi:10.1176/appi.ajp.20240779
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。